Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone

Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone

Purpose: To evaluate whether response assessment of newly diagnosed glioblastoma at 3 months using 11C-methionine-positron emission tomography (MET-PET) is better associated with patient outcome compared with baseline MET-PET or anatomic magnetic resonance imaging alone. Methods and Materials: Patie...

Full description

Bibliographic Details
Main Authors: Sean Miller, BS, Pin Li, MS, Matthew Schipper, PhD, Larry Junck, MD, Morand Piert, MD, Theodore S. Lawrence, MD, PhD, Christina Tsien, MD, Yue Cao, PhD, Michelle M. Kim, MD
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109419301150

Internet

http://www.sciencedirect.com/science/article/pii/S2452109419301150

Similar Items